youtube_live
Fitimet për Q3 2026 • pas 5 ditësh
Shiko detajetchevron_right
LLY:NYSE
Eli Lilly And Co
1 273,46 US$
arrow_downward
-2,49%(-32,54) 1D
1 279,00 US$
arrow_upward
+0,44% (+5,54)bedtimeJashtë orarit
Mbyllur: 23 tet, 4:00:07 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për LLY...
Hap
1 304,15 US$
I lartë
1 307,92 US$
I ulët
1 257,62 US$
Kapitalizimi i tregut
1,20 bln
Vëllimi mesatar
2,31 mln
Vëllimi
2,28 mln
Dividendi
0,54%
Dividendi tremujor
1,73 US$
Data e ndërprerjes së dividendit
14 gush 2026
Raporti çmim/fitim
42,74
Maksimumi 52-javor
1 321,21 US$
Minimumi 52-javor
809,63 US$
Fitimet për aksion
29,80 US$
Beta
0,46
Aksionet në qarkullim
941,36 mln
Numri i punonjësve
50 mijë
Hap
1 304,15 US$
I lartë
1 307,92 US$
I ulët
1 257,62 US$
Kapitalizimi i tregut
1,20 bln
Vëllimi mesatar
2,31 mln
Vëllimi
2,28 mln
Dividendi
0,54%
Dividendi tremujor
1,73 US$
Data e ndërprerjes së dividendit
14 gush 2026
Raporti çmim/fitim
42,74
Maksimumi 52-javor
1 321,21 US$
Minimumi 52-javor
809,63 US$
Fitimet për aksion
29,80 US$
Beta
0,46
Aksionet në qarkullim
941,36 mln
Numri i punonjësve
50 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
3 orë më parë
Eli Lilly's Next-Generation Ovarian Cancer Drug Shows 79% Response Rate, 100% Disease Control In New Data
Zacks
·
17 orë më parë
3 Portfolio-Worthy Stocks Hitting 52-Week Highs: AAPL, LLY & KO
GuruFocus
·
21 orë më parë
Eli Lilly Stocks Slip 1.7% Ahead of Earnings After 48% Revenue G
Traders Union
·
21 orë më parë
LLY declines as overbought conditions weigh on upward momentum
Profili
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Rreth Eli Lilly And Co
Drejtori ekzekutivDavid A. Ricks
Punonjësit50 mijë
Themeluar më1876
SeliaIndianapolis, Indiana, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtililly.com